Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
MARKETS
SECTOR : PHARMA & BIOTECH
INDUSTRY : BIOTECH
PROTAGONIST THERAPEUTICS INC
Protagonist Therapeutics Inc
XNAS: PTGX
Download real time
99.72
-1.96
(
-1.93
%)
New 52W High in past week
213.0K
XNAS Volume
XNAS
20 Mar, 2026 10:40 AM (EDT)
Watchlist
Portfolio
Alert
My Notes
US FDA
Protagonist receives a $50 mn payment from J&J as it receives FDA nod for licensed Icotyde tablets
See details
Overview
Buy Sell Zone
Financials
Technicals
Price History/Seasonality
Ownership
Insider Deals
Corporate Actions
All
Dividend
Split
Board Meetings
About
Protagonist Therapeutics Inc - PTGX - stock price prediction, stock price target, analyst ratings from 12 analysts
Protagonist Therapeutics Inc has a share price target of US$ 112, revenue growth forecast of 950.9%, and profit growth estimate of 255.3% for FY26, based on top 12 analyst calls.
Forecaster Screeners